George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good post Ada
Good to understand your objective better
This is following the general market at the moment .
I truly believe investors will pour in number as everyone want to make money and SN. Will provide to be a reliable cash machine here, give it till March and this will go above 1400 and I have no doubt about it.
I think everyone in market is there for a shock not about this stock but general stock market for shares with potentials we will see massive performance coming to the market and growth and confidence will continue. It will be a recovery year and a year stock market will do so well.
Much better than what people think it would do. So money to be made here and other places.
Miners and energy stocks and some of the key green stocks will be doing so well in coming months. .
My target for exit here is 1800 (at least) and I believe we may see slightly above that potentially this year.
Paitient is the key here
Wish you all the best
My objective from the outset was to research and identify shares that were fundamentally strong enough to come out of Covid restrictions with increasing momentum. Smith and Nephew has both the provenance and capacity to excel. It also has an unbroken dividend record going back 100+ years. I have a working and professional knowledge ofthe fields in which it works and the procurement of its products. It is one of the very few shares that seems comfortable to increase its annual dividend and be extremely highly geared to recovery in elective surgery. Sports injury and the use of S&N products in recovery is increasing exponentially and coverage in US centres outside dedicated medical facilities is growing quickly.
My objective is to protect and increase the value of my p/f and I'm very comfortable here despite the irrational oscillations in share price. I am holding for a flexible period with no set protocol as I believe S&N to be trading at around 60-70% of its true value. Sentiment will turn here, it's just a matter of when. I had expected fund managers with foresight to have boarded already. That has not been the case bit I expect a cascade when they do as Autobot trading will then seriously click in. So we could get a short term lift or a longer term escalator. I'm patient so no problem, but if it seriously went into big overbought then I'd reassess.
Wish you all the best ... I meant
My autocorrect always plays and so annoying
:-)
Ada
I honestly don't know what is your objectives here!
If you are thinking you make loads of money here in 2/4 months I say you are so naive and not fully understood the fundamentals
HOWEVER; if you are here to stay for at least 12 months then you have every chance to almost gain between 40-7
60% from current level
Easy i say
So if this is not your time line you are in the wrong share mate
This will not go up like rocket but it will go up gradually of you willing to HOLD and be paitient
Some of your posts truly worry me to think you are so desperate to get out soon with little profits but this is not that kind of share
You need to analyse the market and fundamentals here
Otherwise you be dossapointed
With you all the best
At least 1400 before March I say if not higher
This is one of the best AIM stock to invest and HOLD for now
GL
Ada
Good
I thought you are about to lose your house over this and wanted the money fast or at a big loss.
So that is good
Keep holding and be paitient this time will come. This will be above 1400 between now and end of March.
GL
Cracking RNS buying competition, adding value & forward thinking. Much better then share buy backs!
In answer to your questions less than six months and current average price now £12.87. No sleepless nights at all with this little gem.
We'll have to agree to differ on that. This morning's RNS is a good indication of the underlying strategy here. The company is building upon it's strengths and whilst a lot of investors are looking at NHS waiting lists the real traction is in in sports and recreational injuries in the USA using it's enviable nationwide coverage. The building blocks are in place and as soon as the markets 'wakes up" to the prospects here the rebound will happen. Today's RNS may well trigger that research and attention. Patience.
Ada
I am sorry mate I think you lost it
How long have you been here? What was your entry?
Take it easy mate
This will not go up like rocket, you have to wait
GL
None of us is figuring on an unexpected reversal in elective surgery in the past 2 months but the price is discounting any horizon scanning as covid recedes.....it really is bizarre. Far from being a basket case, Smith and Nephew could certainly confound all the critics and outperform well into this decade. Not one I'm losing any sleep over just pointing out the discrepancy between current MCap and provenance and potential here where the barrier to entry is significant. Patience.